BERNIE CALDWELL: Open Payments
NPI 1164407896 · WEST MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 21 payments from 14 companies in 2025. Trend: 2023 $630 · 2024 $571 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $96 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Astellas Pharma US Inc | 2 | $43 |
| Novo Nordisk Inc | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Insulet Corporation | 1 | $18 |
Products named: FANAPT, Veozah, VRAYLAR, QULIPTA, Ozempic, AIRSUPRA, CAPLYTA, Kerendia.
Industry payments across LA — which companies pay providers there.
